COMIRNATY COVID-19 mRNA Vaccine

Find COMIRNATY COVID-19 mRNA Vaccine medical information:

Find COMIRNATY COVID-19 mRNA Vaccine medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.




COMIRNATY COVID-19 mRNA Vaccine Quick Finder

The COMIRNATY Product Monograph is available here

COMIRNATY (COVID-19 mRNA Vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Medical Inquiry
Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product:
Canada Vigilance Program 
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.